Dave Huizing - Koninklijke DSM Vice President Investor Relations

KDSKFDelisted Stock  USD 25.30  0.00  0.00%   

President

Mr. Dave Huizing has served as Vice President Investor Relations of Royal DSM NV since July 1, 2012. He started his career in DSM in 1985 as a lawyer. He held positions in Marketing Sales and Key Account Management for DSM Materials businesses, before moving into general management positions, latterly at the Value Assurance Review team. since 2012.
Tenure 12 years
Phone31 45 578 8111
Webhttps://www.dsm.com

Koninklijke DSM Management Efficiency

The company has return on total asset (ROA) of 0.0402 % which means that it generated a profit of $0.0402 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1189 %, meaning that it generated $0.1189 on every $100 dollars invested by stockholders. Koninklijke DSM's management efficiency ratios could be used to measure how well Koninklijke DSM manages its routine affairs as well as how well it operates its assets and liabilities.
Koninklijke DSM NV has accumulated 2.84 B in total debt with debt to equity ratio (D/E) of 0.31, which is about average as compared to similar companies. Koninklijke DSM NV has a current ratio of 2.46, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Koninklijke DSM until it has trouble settling it off, either with new capital or with free cash flow. So, Koninklijke DSM's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Koninklijke DSM NV sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Koninklijke to invest in growth at high rates of return. When we think about Koninklijke DSM's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 9 records

PRESIDENT Age

Masaki MiyajimaShin Etsu Chemical Co
70
Fumio AraiShin Etsu Chemical Co
59
Fabienne LecorvaisierLAir Liquide SA
61
JeanMarc RoyereLAir Liquide SA
58
Louie DAmicoGivaudan SA
62
Armelle LevieuxLAir Liquide SA
50
Michael GraffLAir Liquide SA
68
Pascal VinetLAir Liquide SA
61
Maurizio VolpiGivaudan SA
54
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands. KONINKLIJKE DSM operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 21760 people. Koninklijke DSM NV [KDSKF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Koninklijke DSM NV Leadership Team

Elected by the shareholders, the Koninklijke DSM's board of directors comprises two types of representatives: Koninklijke DSM inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Koninklijke. The board's role is to monitor Koninklijke DSM's management team and ensure that shareholders' interests are well served. Koninklijke DSM's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Koninklijke DSM's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jan Wolters, Head Chemicals
Bruno Mller, Head Products
Paul Gilgen, Head Products
Manfred Eggersdorfer, VP Advocacy
Lieke JongTops, Communications Mang
Geraldine Matchett, CFO and Member of the Managing Board
Luca Rosetto, VP Products
Dimitri Vreeze, Member of the Managing Board
Dave Huizing, Vice President Investor Relations
Rob Atsma, Head Nederland

Koninklijke Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Koninklijke DSM a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Consideration for investing in Koninklijke Pink Sheet

If you are still planning to invest in Koninklijke DSM NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Koninklijke DSM's history and understand the potential risks before investing.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Valuation
Check real value of public entities based on technical and fundamental data
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum